There are errors in the Funding statement. The correct Funding statement is as follows: This work was supported by the Brazilian Council for Scientific and Technological Development (CNPq), grant number 404181/2012-0 to RR, Fundação de Amparo e Pesquisa do Estado do Amazonas (FAPEAM), grant numbers 06200151/2020, 01.02.016301.03393/2021-80 and 01.02.016301.01090/2023-94 to RR, and FAPEAM EDITAL N. 038/2022-PDGD/CAPES/FAPEAM – Coordenador/Auxilio Financeiro. JJ, JS, LS and KLGDQ have fellowships from FAPEAM. JPN and RR are CNPq fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Reference
- 1. Guerra MVdF, de Souza JL, da Silva LS, Júnior JdES, de Mesquita TGR, Queiroz KLGD, et al. Genetic analysis of IFNG-AS1 implicates opposite effects to Leishmania guyanensis-cutaneous leishmaniasis: rs4913269 confers protection while rs7134599 enhances susceptibility and correlates with high plasma IL-4 and IL-10 levels. PLoS Negl Trop Dis. 2025;19(7):e0013318. pmid:40658679
Citation: Guerra MVdF, de Souza JL, da Silva LS, Júnior JdES, de Mesquita TGR, Guimarães KL, et al. (2025) Correction: Genetic analysis of IFNG-AS1 implicates opposite effects to Leishmania guyanensis-cutaneous leishmaniasis: rs4913269 confers protection while rs7134599 enhances susceptibility and correlates with high plasma IL-4 and IL-10 levels. PLoS Negl Trop Dis 19(10): e0013656. https://doi.org/10.1371/journal.pntd.0013656
Published: October 30, 2025
Copyright: © 2025 Guerra et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.